Steven A. Curley
Springer Science & Business Media, Jun 26, 1998 - Medical - 253 pages
Liver Cancer, the inaugural volume in the M.D. Anderson Solid Tumor Oncology series, provides the general surgeon, surgical oncologist, and medical oncologist with the most up-to-date and current standard of multimodality care for hepatobiliary cancer. Surgical approaches, chemotherapy, immunotherapy, gene therapy, and radiotherapy are all presented, giving the practitioner a much needed, comprehensive perspective on all aspects of patient care. The MD Anderson Solid Tumor Oncology series features cutting-edge, indepth information of vital interest to all practitioners in today's captitated financial milieu. Providers must understand how their component of care interdigitates with the varied medical and surgical teams and apply multimodality approaches to their practice environments.
Imaging Studies for Hepatobiliary Tumors
Surgical Management of Hepatocellular Carcinoma
Chemotherapy for Hepatocellular Carcinoma
Use of Chemoradiation for Management of Cholangiocarcinoma
Alternative Treatment Approaches to Early Stage or Unresectable Hepatocellular Carcinoma Confined to the Liver
Treatment of Cholangiocarcinoma
Diagnosis and Treatment of Primary Gallbladder Cancer
Hepatic Resection for Colorectal Cancer Metastases
Other editions - View all
5-year survival ablation Ann Surg blood catheter chemoembolization chemoradiation chemotherapy cholangiocarcinoma cholecystectomy cirrhosis cirrhotic clinical colorectal cancer colorectal carcinoma cryosurgery cryotherapy CT scan curative Curley detection diagnosis disease-free distal dose doxorubicin drug enhancement evaluation ExBRT extrahepatic disease factors floxuridine freezing FUDR gallbladder cancer gallbladder carcinoma gene growth HCC patients hemangiomas hepatic arterial infusion hepatic cryosurgery hepatic metastases hepatic resection hepatic vein hepatocellular carcinoma hepatocytes iceball imaging injection intrahepatic intraoperative intravenous invasion irradiation lesions ligated liposomes liver cancer liver failure liver metastases liver resection liver transplantation liver tumors lobe lymph node malignant margin median survival metastases from colorectal necrosis normal parenchyma patic patients treated patients undergoing patients with HCC percutaneous perihilar portal vein postoperative preoperative primary tumor prognostic pump Radiology receptor recurrence regimens reported resection response rates Surgery surgical resection survival rates technique tion tissue toxicity treatment tumor cells ultrasonography vascular vector venous World J Surg
Page 2 - The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd. Houston, TX 77030. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1 734 solely to indicate this fact.